| ★ | Saroglitazar Targets Bile Acid Dysregulation, Inflammation in PBC, With Raj Vuppalanchi, MD | | 55 | Estados Unidos | |
| 7 | The Cholesterol War Is Over (Here's Who Won) | Dr Brad Stanfield @drbradstanfield | 147.6K | Nueva Zelanda | 83 |
| 17 | Healing Inflammation Naturally: A Case of Cardiac Sarcoidosis | Montgomery Heart & Wellness @montgomeryheartwellness | 4.8K | Estados Unidos | 83 |
| 10 | COLANGITE BILIARE PRIMITIVA: LE NUOVE CLASSI DI FARMACI MIGLIORANO PROGNOSI E QUALITA' DI VITA | MedicinaInformazione @medicinainformazione | 912 | Italia | 83 |
| 8 | Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B | | 521 | Estados Unidos | 83 |
| 14 | Phase 2b VISTAS: Volixibat Improves #CholestaticPruritus Within 2 Weeks | | 488 | Estados Unidos | 83 |
| 11 | GDF2026 - Updates on Nitrosamines/ Nitrosamine Mitigation Strategies for Pharmaceuticals | U.S. Food and Drug Administration @us_fda | 409 | Estados Unidos | 83 |
| 19 | Update on B cell targeting therapies in IgG4-related disease | | 375 | — | 82 |
| 6 | Atacicept Approval Brings BAFF/APRIL Targeting to IgAN With Richard Lafayette, MD | | 173 | Estados Unidos | 83 |
| 13 | Rapid Evolution in GLP-1s and Therapeutics at ADA 2026 | | 171 | Estados Unidos | 83 |
| 5 | GDF2026 - Overview of the FDA Product-Specific Guidance (PSG) Program | U.S. Food and Drug Administration @us_fda | 166 | Estados Unidos | 83 |
| 2 | Volixibat Improves Itch, Fatigue in PSC, Supporting “Patient-Centered” Care, With Gideon Hirschfield | | 134 | Estados Unidos | 86 |
| 1 | Looking Beyond ALP Response in PBC With Saroglitazar, With Raj Vuppalanchi, MD | | 68 | Estados Unidos | 95 |
| 18 | Addressing Advances and Roadblocks in Lipid Management, With Joseph Saseen, PharmD | | 64 | Estados Unidos | 82 |
| 3 | Volixibat Improves Itch, Fatigue in PSC, Supporting “Patient-Centered” Care | | 59 | Estados Unidos | 85 |
| 4 | GDF2026 - Product-Specific Guidances (PSGs) in Action – Key Lessons and Common Questions | U.S. Food and Drug Administration @us_fda | 58 | Estados Unidos | 84 |
| 15 | GDF2026 - Decoding PSGs for Complex Non-Oral Generics | U.S. Food and Drug Administration @us_fda | 49 | Estados Unidos | 83 |
| 9 | Jornada divulgativa: Avances en Arica del proyecto contra el cáncer de vesícula biliar | Universidad de Tarapacá @utaplay | 40 | Chile | 83 |
| 20 | Update 3a edición. In personalized immunosuppression | Hospital Universitari de Bellvitge @bellvitgehospital | 35 | España | 82 |
| 16 | B-Cell–Targeted Therapies Expand in IgA Nephropathy, With Samir Parikh, MD | | 27 | Estados Unidos | 83 |
| 12 | GDF2026 - Proactive Strategies to Avoid Major Filing Deficiencies and Other Filing Stumbling Blocks | U.S. Food and Drug Administration @us_fda | 25 | Estados Unidos | 83 |